Clinical trial
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder…
NCT00332319 · GlaxoSmithKline, Industry · Terminated
Key facts
| NCT number | NCT00332319 |
|---|---|
| Title | Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients |
| Official title | See Detailed Description |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Incontinence, Urinary and Urinary Bladder, Overactive, Overactive Bladder |
| Intervention type | Drug |
| Interventions | GW679769 |
| Enrollment | 1 |
| Start date | Jan 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jun 1, 2006 |
| Last update posted | Apr 17, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: